(165) Mount Sinai Medical Center New York — New York, New York

(165) Mount Sinai Medical Center New York is a clinical research site located in New York, New York, United States 10029-65749.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

(165) Mount Sinai Medical Center New York has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Acute Myelogenous Leukemia.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for (165) Mount Sinai Medical Center New York?

(165) Mount Sinai Medical Center New York has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has (165) Mount Sinai Medical Center New York conducted?

(165) Mount Sinai Medical Center New York has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia, Acute Myelogenous Leukemia.

Is (165) Mount Sinai Medical Center New York accredited by Crixeo Health?

(165) Mount Sinai Medical Center New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about (165) Mount Sinai Medical Center New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.